Research · 7 min read
Safety Profile of Leave-On AHAs
Long-term safety data for daily AHA use at 5–10%.
Updated 11 June 2026 · Reviewed by GlycolicAcid.com.au editorial
Pooled safety data from 12 studies (n>2,400) shows transient erythema as the most common adverse event (12%), with no sustained barrier impairment beyond 4 weeks.
Continue reading